Controlled Acute Hypoxia Study - Abbreviated Sensor Line

NCT02216344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2016-09-30

No results posted yet for this study

Summary

The primary objective of the study is to validate the proposed claims for the OxiCable device, for pulse rate and saturation accuracy in a diverse subject population over a specified saturation range.

Conditions

Sponsors & Collaborators

  • Medtronic - MITG

    lead INDUSTRY

Principal Investigators

  • Eric T Heyer, MD · Medtronic - MITG

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02216344 on ClinicalTrials.gov